Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Colorcon
Boehringer Ingelheim
Moodys
Medtronic
Johnson and Johnson
Merck

Last Updated: December 12, 2019

DrugPatentWatch Database Preview

Litigation Details for Boston Scientific Corporation v. Johnson and Johnson Inc. (D. Del. 2007)

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Boston Scientific Corporation v. Johnson and Johnson Inc. (D. Del. 2007)

Docket   Start Trial Date Filed 2007-06-01
Court District Court, D. Delaware Date Terminated 2010-01-20
Cause 35:145 Patent Infringement Assigned To Sue Lewis Robinson
Jury Demand Both Referred To
Parties BOSTON SCIENTIFIC CORPORATION; BOSTON SCIENTIFIC SCIMED INC.; CORDIS CORPORATION; JOHNSON & JOHNSON; WYETH
Patents 5,362,718; 5,378,475
Attorneys Andrew Auchincloss Lundgren; David T. Pritikin; John G. Day; Jon M. Spanbauer; Josy W. Ingersoll; Karen Elizabeth Keller; Karen L. Pascale; Lauren E. Maguire; Russell E. Cass; Steven J. Balick; Tiffany Geyer Lydon; William H. Baumgartner
Link to Docket External link to docket
Small Molecule Drugs cited in Boston Scientific Corporation v. Johnson and Johnson Inc.
The small molecule drugs covered by the patents cited in this case are   Start Trial and   Start Trial .

Details for Boston Scientific Corporation v. Johnson and Johnson Inc. (D. Del. 2007)

Date Filed Document No. Description Snippet Link To Document
2007-06-01 1 Complaint /1991 Hsn ........................... 604/266 5,378,475 A 1/1995 smith er s1. ................ 424/473…States Patent No. 7,223,286 (“the Wright 3286 patent”). The Wright 3286 patent issued from the Patent Off…the ’764 and ’536 patents are part of the same patent family as the Wright ’286 patent and the Falotico… of the ‘286 patent, and is infringing the ‘286 patent with knowledge of Cordis’s patent rights. Abbott…least the Wright ’764 patent, the Wright ’536 patent, and United States Patent No. 6,776,796 (“the Falotico External link to document
2009-06-25 221 5,362,718 (“the ”?l 8 patent”) to the PTO. Upon information and belief, one or more of the Applicants…reasonable Patent Examiner would have considered the ’579 patent important to the patentability of the claims…reasonable Patent Examiner would have considered the ")'90 patent important to the patentability of …reasonable Patent Examiner would have considered the ’71 8 patent important to the patentability of the claims…reasonable Patent Examiner would have considered the ’ l 730 patent important to the patentability 0ftl' External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Colorcon
Dow
Harvard Business School
Baxter
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.